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Background: To investigate the clinicopathological characteristics of respiratory epithelial adenomatoid hamartoma
(REAH) in residents of Southern China and to study the correlation between REAH and Epstein-Barr virus (EBV).
Methods: Clinicopathological data of 53 cases of REAH were retrospectively analyzed. The immunoreactivity for
CK 7, CK20, CEA, p53, and Ki-67, Alcian blue–periodic acid-Schiff (AB-PAS) staining and in situ hybridization for
EBV-encoded RNA (EBER) were carried out.
Results: REAH lesions were covered with ciliated columnar epithelium and proliferation of subepithelial glands,
which were positive for CK7, and negative for CK20, CEA, and p53. Goblet cell metaplasia was stained blue by
AB-PAS. The frequency of EBER positive cases in REAH located in nasopharynx was 27.78%, compared with that in
the nasal cavity (15.79%) and paranasal sinuses (12.50%), there were no statistical differences.
Conclusions: REAH is an uncommon entity with distinctive morphologic features and EBV may have nothing to do
with REAH.
Virtual slides: The virtual slide(s) for this article can be found here:
http://www.diagnosticpathology.diagnomx.eu/vs/5875687401178748
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The term “hamartoma” was introduced by Albrecht in
1904 to distinguish between true neoplasms and tumor-
like lesions [1]. In 1934, Goldsworthy applied this term
to a benign tumor in the lung composed predominantly
of a combination of fat and cartilage [2]. This term is
now used to designate a focal overgrowth of mature nor-
mal cells and tissues at sites of identical cellular compos-
ition; thus, a hamartoma may occur in any organ. It
may arise from any of the germ layers and does not
metastasize. Although hamartomas have been described
as occurring throughout the body, they are rare in the
upper aerodigestive tract [3]. Respiratory epithelial ade-
nomatoid hamartoma (REAH) was first described in
1995 by Wenig and Heffner in a series of 31 cases [4].
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unless otherwise stated.proliferation of glandular tissue surrounded by a thick
eosinophilic basement membrane within ciliated respira-
tory epithelium with no evidence of atypical or meta-
plastic changes in the squamous cells.
To date, there is limited literature regarding REAH
[5]. In particular, no studies of REAH have been carried
out in Cantonese individuals living in the central region
of Guangdong Province in Southern China. Nasopharyn-
geal carcinoma (NPC) is common among the Cantonese,
and Epstein-Barr virus (EBV) has been considered cru-
cial for NPC cloning [6]. In the current study, we ana-
lyzed the clinicopathological characteristics of REAH in
residents of Southern China and the correlation between
EBV and REAH.Materials and methods
Ethics statement
This study was carried out according to the principles
of the Declaration of Helsinki and approved by the Insti-
tutional Review Board of the Fourth Affiliated Hospital
of Jinan University and Nanfang Hospital of Southern. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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formed consent for the collection of samples and subse-
quent analysis.
The medical records of all 53 patients who were diag-
nosed with REAH between January 1998 and May 2011
were analyzed. Demographic and clinical data were ob-
tained retrospectively from their hospital medical re-
cords, and paraffin-embedded tissue samples and slides
were obtained from the Department of Pathology at
the Fourth Affiliated Hospital of Jinan University and
Nanfang Hospital of Southern Medical University in
Guangzhou, China. All patients data and samples were
anonymized before use. All of the slides were independ-
ently reviewed by five experienced pathologists to reach
a diagnosis by consensus.
Immunohistochemistry and AB-PAS histochemical staining
Ten sections, each 4 μm in thickness, were cut from the
paraffin blocks of the REAH lesions. Consecutive sec-
tions were used to make an optimal comparison between
morphology and protein expression. Immunohistochem-
ical staining for cytokeratin (CK) 7, carcinoembryonic
antigen (CEA), 34βE12, p63, p53, and Ki-67 was carried
out as described elsewhere [7]. Primary antibodies
against CK7 (clone OV-TL 12/30, 1:100 dilution), CEA
(clone Ks20.8, 1:50 dilution), Collagen IV(clone PHM-
12, 1:100 dilution), p63 (clone 4A4, 1:200 dilution), p53
(clone DO-7, 1:100 dilution), and Ki-67 (clone MIB-1,
1:25 dilution) were obtained from Dako Corporation
(Glostrop, Denmark). Appropriate positive and negative
controls were run in each case. As negative staining con-
trols, the primary antibodies were replaced with the pri-
mary antibody diluents.
Alcian blue–periodic acid-Schiff (AB-PAS) staining
was carried out by immersing each section in a solution
of alcian blue and 3% acetic acid for 30 min, then in
Schiff ’s reagent for 15 min to promote oxidation, and
then counterstaining it in hematoxylin.
In situ hybridization for EBER
To determine the correlation between EBV and REAH,
we divided our tissue samples into 4 groups: Group 1
consisted of normal tissue from the nasal cavity and
paranasal sinuses mucosa (31 samples); group 2 con-
sisted of REAH tissue taken from the same structures
(31 samples); group 3 consisted of normal mucosal tis-
sue from the nasopharynx (22 samples); and group 4
consisted of REAH tissue taken from the nasopharynx
(22 samples).
In situ hybridization was performed using a flourescein-
conjugated EBV peptide nucleic acid (PNA) probe (Dako)
for EBV-encoded RNA (EBER) according to the manufac-
turer’s instructions. After the sections were dewaxed, they
were rehydrated in graded alcohol and distilled water andpredigested with proteinase K. A hybridization solution
containing the fluorescein-conjugated EBV nucleic acid
probe was then applied, followed by the application of
alkaline-phosphatase–conjugated antibody to fluorescein
isothiocyanate. Bromochloroindolyl phosphate/nitro blue
tetrazolium chloride (BCIP/NBT) combined with levami-
sole was applied to serve as the chromogen. The slides
were then lightly counterstained with hematoxylin. Dark
blue or black staining of the nucleus served as a signal of
hybridization. Positive and negative control slides were run
for each specimen by replacing the EBV probe with a posi-
tive or negative fluorescein-conjugated PNA probe (Dako).
Statistical analysis
The staining results of EBERs in REAH tissues were ana-
lyzed using Fisher’s exact test in comparison with that of
control group obtained from corresponding normal tis-
sue. p value of less than 0.05 was considered significant.
Results
A total of 53 patients completed the study. They included
25 women and 28 men with an average age of 48.12 years
(range: 17–64 years). Patient demographics are summa-
rized in Table 1. Of these patients, 20.76% (n = 11) had
surgery for chronic sinusitis, 45.28% (n = 24) had surgery
for polyps, and 33.96% (n = 18) had a biopsy for suspicion
of NPC.
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Preoperative computed tomography (CT) scans ordered by
their primary care physicians revealed no distinguishing
features that could be used to confirm REAH. CT scans
showed soft tissue masses in the nasal cavity or paranasal
sinuses and thickening (to some extent) of the mucosa
in the maxillary sinus, ethmoid sinus, frontal sinus and
sphenoid sinus. Radiographic imaging revealed mainly
chronic sinusitis and nasal polyps (Figure 1A). Additional
CT findings included bony irregularities in the lateral max-
illary wall and orbital floor. In patients with REAH in the
nasopharynx, CT scans revealed thickening of the nasopha-
ryngeal wall, the disappearance or flattening of pharyngeal
recesses, and filling of the nasopharyngeal cavity with soft
tissue masses but no sign of destruction of craniobasilar
bone or swelling of cervical lymph nodes (Figure 1B).
Histologic features
A histopathological examination revealed that REAH le-
sions were covered with ciliated columnar epithelium and
a proliferation of subepithelial glands. These glands were
typically round to oval in shape and small to medium
in size with a prominent dilation, unlike the cribriform
glandular growth often seen in more aggressive tumors
(Figure 2A). The glands were lined with cuboidal or flat
ciliated epithelial cells (Figure 2B). Metaplasia was often
observed in the mucinous glands, and most of the meta-
plastic cells were goblet cells (Figure 2C). A characteristic
finding was stromal hyalinization with a thick eosinophilic
basement membrane separating the glands (Figure 2D).
Other histologic features included fibroblastic proliferation,
stromal edema, and a mixed inflammatory cell infiltrate.
Immunohistochemistry and histochemical staining
Stromal epithelial components of REAH tissue were posi-
tive for CK7 (Figure 3A) and negative for CK20. BothFigure 1 Computed tomography scans of REAH. A. Axial CT showing so
sinus thickening in some extent. B. Additional CT of maxilla. Additional CT Noepithelial components and basal cells were negative for
p53. p63 outlining the basal cell layers around glands
inREAH (Figure 3B) and Ki-67 staining was only localized
to the basal layer, where it indicated the lowest mean la-
beling index of any group of lesions (<1%) (Figure 3C).
The distinctive hyalinized basement membrane that sur-
rounds the ciliated epithelium was positive for collagen IV
(Figure 3D). Compared with that of normal ciliated re-
spiratory epithelium, more mucins took up the blue AB-
PAS stain in the glandular epithelium of REAH (Figure 4).
EBER in situ hybridization
In situ hybridization was used to detect the expression of
EBER in REAH tissue. As shown in Figure 5, EBER was
found sporadically positive expressed in some of the ob-
tained tissues and black/dark brown signal was localized
to the nuclei of affected cells. As shown in Table 2, among
the various locations from which REAH tissue was ob-
tained, EBV was found sporadically in REAH epithelial
cells in 15.79% (3/19) of tissue samples obtained from the
nasal cavity, 12.50% (2/16) of tissue from the paranasal si-
nuses, and 27.78% (5/18) of tissue from the nasopharynx.
Although EBER was found most frequently in the naso-
pharynx, the difference in frequency in the nasopharynx
compared with the other sites was not statistically signifi-
cant (P = 0.268). Additionally, 10.53% (2/19) of tissue sam-
ples obtained from the nasal cavity, 18.75% (3/16) of tissue
samples from the paranasal sinuses, and 22.22% (4/18) of
tissue samples from the nasopharynx were shown EBER
sporadically positive (Figure 5). There was also no statis-
tical difference in EBER expression between REAH and
normal mucosal tissue.
Discussion
REAH is an expansile mass that causes upper respiratory
symptoms and discomfort mainly in adults [5]. Symptomsft tissue masses in both nasal cavities, mucosa in maxillary sinus, ethmoid
te occlusion of right posterior choana and nasopharynx by mass.
Figure 2 Respiratory epithelial adenomatoid hamartoma. A. The glands proliferated with various sizes (hematoxylin-eosin, 20×). B. The
glands were lined by ciliated respiratory epithelium (hematoxylin-eosin, 20×). C. Most of the ciliated respiratory epithelial are metaplastic goblet
cells (hematoxylin-eosin, 40×). D. The glands were surround by thick eosinophilic and hyalinizated basement membranes
(hematoxylin-eosin, 20×).
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pany chronic sinusitis, eg, nasal congestion, nasal obstruc-
tion, headaches, facial pain, epistaxis, and hyposmia.
Endoscopy does not reveal any distinguishing features to
suggest a diagnosis of REAH, and neither CT nor mag-
netic resonance imaging produces a specific signal inten-
sity that can help the clinician distinguish REAH from
other sinus lesions [3,8,9]. Distinctive histologic features
of REAH include a glandular component that originates in
the overlying surface respiratory epithelium and polypoid
growths that represent a proliferation of respiratory epi-
thelial adenomatoid tissue [5]. It is important to recognize
this lesion, however, because it can be confused histo-
pathologically with other disease processes that require a
significantly different treatment approach. Included in the
microscopic differential diagnosis of REAH are inflamma-
tory polyps [4,9,10], inverted Schneiderian papillomas
[3,4,10,11], and well-differentiated adenocarcinoma [3,11].
Pathologists must be aware of this entity to avoid overdi-
agnosis and overly aggressive surgical procedures.
Mucins are conventionally classified as neutral mucins
or acid mucins (the latter comprising sulfomucins and
sialomucins) according to the color reaction obtained
with histochemical stains such as periodic acid–Schiff
(PAS) and Alcian blue (AB) at pH 2.5 [12]. Airway mucinsare produced by two different types of cells: goblet cells in
the surface epithelium and mucous cells in submucosal
glands. In our study, more mucins took up the blue AB-
PAS stain in REAH tissue than in controls. This suggests
that REAH-associated metaplasia develops predominantly
in the goblet cells in ciliated respiratory epithelial tissue
and that acid mucin production is increased in the airways
of patients with this disease.
Mucus protects the underlying airway epithelium from
dehydration and from damage by pathogens or chemical
and particulate irritants [13,14]. It has been proposed
that an abnormal increase in mucus secretion promotes
bacterial adhesion and inhibits bacterial clearance by im-
peding cilial function [15,16], which may exacerbate
symptoms in patients with REAH.
REAH is frequently associated with inflammatory polyps,
although it has been suggested that these polyps arise sec-
ondary to the inflammatory process. The mechanisms re-
sponsible for inducing REAH are still unknown.
To date, there has been only one study of the molecu-
lar genetics of REAH. Ozolek and Hunt showed that
patients with REAH lack heterozygosity for loci on chro-
mosomes 9p and 18q and exhibit a fractional allelic loss
of 31%, which the authors concluded was unusually high
for a nonneoplastic entity. They suggested that REAH
Figure 3 Representative immunohistochemical staining results of REAH. A. REAH stained with cytokeratin 7 shows diffuse predominantly
strong staining of the glandular epithelium. B. p63 outlining the basal cell layers around glands in REAH. C. Ki-67 staining was localized to the
basal layer with a labeling index less than 1%. D. The distinctive hyalinized basement membrane that surrounds the ciliated epithelium was
highlighted by Collagen IV.
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toma, as was originally believed [17]. In our study, the
nuclear features of REAH were bland and both epithelial
components and basal cells were negative for p53. Ki-67
staining was only localized to the basal layer and the la-
beling index less than 1%. These findings support the be-
nign nature of the lesion.Figure 4 Alcian blue–periodic acid–Schiff Histochemical Staining. Com
cavity mucosa (B), more mucins took up the blue AB-PAS stain in the glanREAH is a rare lesion that is limited to the nasal cavity,
paranasal sinuses, and nasopharynx. Wenig and Heffner
estimated that approximately 70% of REAH tissue is in
the nasal cavity and 9.68% is in the nasopharynx [4]. How-
ever, our data, suggest that 35.85% of REAH tissue is in
the nasal cavity, 30.19% in the paranasanl sinuses and
33.96% in the nasopharynx.pared with the respiratory epithelium of normal tissue from the nasal
dular epithelium of REAH (A).
Figure 5 Epstein-Barr virus–encoded RNA (EBER) in-situ hybridization (ISH) of REAH. Black/dark brown signal is localized to the nuclei of
affected cells. A (nasal cavity), B (paranasal sinuses) and C (nasopharynx) showing REAH with rare positive cell for EBER. D. Results of EBER positive
rate compared with that of corresponding normal tissue.
Hua et al. Diagnostic Pathology 2014, 9:70 Page 6 of 7
http://www.diagnosticpathology.org/content/9/1/70NPC is a nonlymphomatous squamous-cell carcinoma
that arises in the epithelial lining of the nasopharynx. This
neoplasm is uncommon in most countries, with an age-
adjusted incidence in both sexes of fewer than 1:100,000. It
occurs with much greater frequency in Southern China,
however, especially among Chinese people living in the
province of Guangdong (25 to 30:100,000 annually) [18-20].
In contrast to other head and neck cancers and to epithelial
malignancy in general, NPC is unique in terms of its strong
association with EBV, which is consistently detected in pa-
tients with NPC, whether they are from regions with a high
or low incidence of NPC [21,22].
The EBER signal has been shown through in situ
hybridization to be present in nearly all tumor cells. In
NPC cells, EBV exists as an episome and is not inte-
grated into the host genome. EBV adopts a specific formTable 2 EBV-encoded small RNAs staining in REAH and
corresponding normal tissues
Lesion location Positively stained for EBERs pa value
REAH Normal tissue
Nasal cavity 3/19 (15.79%) 2/19 (10.53%) 0.523
Paranasal sinuses 2/16 (12.50%) 3/16 (18.75%) 0.527
Nasopharynx 5/18 (27.78%) 4/18 (22.22%) 0.530
aDerived from Fisher’s exact test as comparison with the control groups.
EBERs = EBV-encoded small RNAs.of latent infection, latency II, in NPC cells. Only a lim-
ited number of viral gene transcripts—including tran-
scripts for EBER, EBNA1, LMP1, LMP2, BARF1, and
several BamHIs—are expressed. A latent EBV infection
may take place before expansion of the malignant cell,
which would indicate that EBV plays a critical role in
transforming nasopharyngeal epithelial cells into an in-
vasive form of cancer [22-24].
In our study, all of the patients were from Guangdong,
and most of their REAH lesions were found in the naso-
pharynx. To the best of our knowledge, ours was the
first attempt to study the correlation between EBV and
REAH in Southern China.
In situ hybridization has been proven to be a valuable
molecular tool for the diagnosis and understanding of
viral and neoplastic disease [25,26]. This test provides
optimal DNA detection sensitivity of approximately
40 kb in tissue sections and 10 to 20 copies of mRNA or
viral DNA per cell. It is more sensitive to EBER than
polymerase chain reaction analysis in the search for EBV
latency in tissues and allows for localization of the EBV
signal in tumor cells. In situ hybridization of EBER was
reported to have a sensitivity of 98% and a specificity of
100% in detecting primary NPC.
The cancer-associated herpesvirus EBV infects more
than 90% of the world’s population. Initial infection of
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nucleosis syndrome. Several neoplasms have been shown
to be associated with EBV as evidenced by the presence
of EBV genome in the tumor cells [27]. In our study,
EBER was found sporadically positive expressed in some
of the obtained tissues. Despite the fact that EBER was
detected more frequently in REAH tissue, we found no
statistically significant difference in EBV latency among
tissues obtained from the nasal cavity, paranasal sinuses,
and nasopharynx of patients with REAH or between
REAH and normal mucosal tissue. We concluded that
EBV may have nothing to do with REAH. These obser-
vations lend support the suggestion that REAH is a re-
active rather than neoplastic lesion. Further investigation
through molecular studies will be essential to further
our understanding of the pathogenesis of this disease.
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